Skip to main content
SpringerLink
Log in

Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg

  • Service
  • Published:
Tijdschrift voor gezondheidswetenschappen Aims and scope

samenvatting

Het doel van de kostenhandleiding is het verschaffen van een instrument dat onderzoekers en beleidsmakers faciliteert bij de uitvoering en beoordeling van kostenonderzoek in economische evaluaties. In dit artikel wordt de kern van de kostenhandleiding 2010 beschreven en in een internationale context geplaatst aan de hand van het stappenplan voor kostenonderzoek. In dit stappenplan wordt het berekenen van kosten gezien als een proces waarbij zeven stappen chronologisch doorlopen worden. Waar duidelijke aanbevelingen worden gedaan voor de bepaling van de reikwijdte van de economische evaluatie (stap 1), de keuze van de kostencategorieën (stap 2), omgaan met onzekerheid (stap 6) en rapportage van kosten (stap 7), wordt de keuze met betrekking tot de identificatie (stap 3), volumemeting (stap 4) en waardering van eenheden (stap 5) neergelegd bij de onderzoeker. Hoewel de aanbevelingen in Nederland op specifieke onderwerpen iets afwijkt van andere Westerse landen, is het stappenplan voor kostenonderzoek vergelijkbaar met het proces dat beschreven wordt in de internationale richtlijnen. De kostenhandleiding sluit aan bij de uitgangspunten en de terminologie uit de Nederlandse richtlijnen voor farmaco-economisch onderzoek, maar de beschreven methoden kunnen ook in andere soorten onderzoekworden gebruikt.

Abstract

Update of the Dutch ‘Manual for costing in economic evaluations’ The aim of the costing manual is to furnish researchers and policymakers with an instrument to facilitate the implementation and assessment of costing studies in economic evaluations. The present study describes the main content of the costing manual 2010 and position it in the international context by means of the cost study action plan. The cost study action plan treats cost studies as a chronological, 7-step process. Where recommendations regarding the choice of the scope of the economic evaluation (step 1), cost categories (step 2), dealing with uncertainty (step 6) and cost reporting (step 7) are clear, the choices regarding the identification (step 3), measurement (step 4) and valuation of resource quantities (step 5) is left to the researcher. Although the cost study action plan is quite similar to the process described in most health economic guidelines issued in Europe, North America and Australia, the recommendations on particular aspects differ between national guidelines in some respects. The costing manual was published for use together with the Dutch ‘Guidelines for Pharmacoeconomic Research’, but the methods may also be used for other kinds of research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  1. Rutten-van Molken M. Van kosten tot effecten: een handleidingvoor evaluatiestudies in de gezondheidszorg. Maarssen; Elseviergezondheidszorg, 2010.

    Google Scholar 

  2. Commonwealth of Australia. Manual of recourse items and their associated costs 2009. Canberra: Commonwealth of Australia:, 2009.

    Google Scholar 

  3. Rodenburg-van Dieten HEM. Richtlijnen voor farmaco-economisch onderzoek; evaluatie en actualisatie. Diemen: College voor zorgverzekeringen, 2005.

    Google Scholar 

  4. Tan SS, Bouwmans CAM, Rutten FFH, Hakkaart-van Roijen L. Update of the Dutch Manual for costing in economic evaluations. Int J Technol Assess Health Care; 28:2 (2012), 152–158.

    Article  PubMed  Google Scholar 

  5. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines–similarities, differences and some implications. Value Health 2001;4:225–50.

    Article  PubMed  CAS  Google Scholar 

  6. Rappange DR, Baal PH van, Exel NJ van et al. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 2008;26:815–30.

    Article  PubMed  Google Scholar 

  7. Swindle R, Lukas CV, Meyer DA, Barnett PG, Hendricks AM. Cost analysis in the Department of Veterans Affairs: consensus and future directions. Med Care 1999;37:AS3–8.

    Article  Google Scholar 

  8. Clement Nee Shrive FM, Ghali WA, Donaldson C, Manns BJ. The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs grosscosting approaches. Health Econ 2009;18:377–88.

    Article  Google Scholar 

  9. Tan SS, Rutten FF, Ineveld BM van, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ 2009;10: 39–45.

    Article  PubMed  CAS  Google Scholar 

  10. Tan SS. Microcosting in Economic Evaluations: Issues of accuracy, feasibility, consistency and generalisability. Rotterdam: Erasmus Universiteit, 2009.http://publishing.eur.nl/ir/repub/asset/17354/091127_Tan,%20Siok%20Swan.pdf.

    Google Scholar 

  11. Ellwein LB, Drummond MF. Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes. Int J Technol Assess Health Care 1996;12:691–7.

    Article  PubMed  CAS  Google Scholar 

  12. Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess 1999;3:1–76.

    PubMed  CAS  Google Scholar 

  13. Raftery J, Roderick P, Stevens A. Potential use of routine databases in health technology assessment. Health Technol Assess 2005;9:1–92,iii–iv.

    CAS  Google Scholar 

  14. Curtis L. Unit Costs of Health and Social Care 2010. Eighteenth edition. Canterbury: University of Kent, 2010.

    Google Scholar 

  15. Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B. Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005;67:736–46.

    Article  PubMed  CAS  Google Scholar 

  16. Tan SS, Ineveld BM van, Redekop WK, Hakkaart-van Roijen L. The Netherlands: the Diagnose Behandeling Combinaties (DBCs). In: Busse R, Geissler A, Quentin W & Wiley MM (eds). Diagnosis-Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals. Buckingham: Open University Press and WHO Regional Office for Europe, 2011.

    Google Scholar 

  17. Goossens ME, Rutten-van Molken MP, Vlaeyen JW, Linden SM van der. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53:688–95.

    Article  PubMed  CAS  Google Scholar 

  18. Brink M van den, Hout WB van den, Stiggelbout AM et al. Selfreports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care 2005;21:298–304.

    PubMed  Google Scholar 

  19. Wordsworth S, Ludbrook A, Caskey F, Macleod A. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ 2005;6:38–44.

    Article  PubMed  Google Scholar 

  20. Zuurbier J, Krabbe-Alkemade Y. Onderhandelen over DBC’s. Maarssen: Elsevier Gezondheidszorg, 2007.

    Google Scholar 

  21. Jackson T. Cost estimates for hospital inpatient care in Australia: evaluation of alternative sources. Aust N Z J Public Health 2000;24:234–41.

    Article  PubMed  CAS  Google Scholar 

  22. Heerey A, McGowan B, Ryan M, Barry M. Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation. Expert Rev. PharmacoEconomics Outcomes Res 2002;2:29–33.

    Article  Google Scholar 

  23. Raikou M, Briggs A, Gray A, McGuire A. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. Health Econ 2000;9: 191–8.

    Article  PubMed  CAS  Google Scholar 

  24. Tan SS, Gils CW van, Franken MG et al. The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology. Value Health 2010; 13:712–9.

    Article  PubMed  Google Scholar 

  25. Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ 2011;20:2–15.

    Article  PubMed  Google Scholar 

  26. Brouwer WB, Niessen LW, Postma MJ, Rutten FF. Need fordifferential discounting of costs and health effects in costeffectiveness analyses. BMJ 2005;331:446–8.

    Article  PubMed  Google Scholar 

  27. Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ 2007;16:307–17.

    Article  PubMed  Google Scholar 

  28. Briggs AH, Goeree R, Blackhouse G. Probabilistic analysis of costeffectiveness models; choosing between treatment strategies for gastroesophagal reflux disease. Medical Decision Making 2002;22:290–308.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands

    Siok Swan Tan, Clazien A. M. Bouwmans-Frijters & Leona Hakkaart-van Roijen

Authors
  1. Siok Swan Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clazien A. M. Bouwmans-Frijters
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leona Hakkaart-van Roijen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Correspondentieadres

Dr. Siok Swan Tan, institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, Postbus 1738, 3000 DR Rotterdam, tel. 010-4088623, e-mail: tan@bmg.eur.nl

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swan Tan, S., Bouwmans-Frijters, C. & Hakkaart-van Roijen, L. Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg. Tijds. gezondheids.wetenschappen 90, 367–372 (2012). https://doi.org/10.1007/s12508-012-0128-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12508-012-0128-3

Trefwoorden

Keywords

Search

Navigation